Lisa Lynn Decker, CHIEF BUSINESS OFFICER at IGM Biosciences, Inc. (IGMS), sold 977 shares at $7.58 ($7K) on 2024-06-14, disclosed to the SEC on 2024-06-18.
Open-market sale of $7k IGMS by CHIEF BUSINESS OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IGMS | SELL | 2025-03-18 | $6K | — | Filing → |
| IGMS | SELL | 2024-12-18 | $8K | — | Filing → |
| IGMS | SELL | 2024-09-17 | $11K | — | Filing → |